Articulating Value: Dr. Phares Moderates Reuters Pharma USA Panel Session

  • March 16, 2022 - 4:50pm - 5:30pm

NPC's Chief Scientific Officer Sharon Phares led a panel session that explored the role of clearly articulating value to successfully maneuver the market landscape.

Reuters 2022
Sharon Phares
Sharon Phares, PhD, MPH

NPC Chief Scientific Officer Sharon Phares moderates session at this year's Reuters Pharma USA 2022

March 16 -17, 2022 | Philadelphia, PA

 

 

 

Panel Session: "Your role in clearly articulating value to successfully maneuver the market landscape"

March 16 | 4:50 p.m. - 5:30 p.m. 

Discussion topics:

  • Ensuring access to treatment, balancing multiple stakeholders, and delivering on your social responsibility
  • Developing high-impact communications to tell the value story of our industry and of your products
  • Anticipating new health care market trends to make sure unmet needs are being addressed

Panelists:

  • Indranil Bagchi, SVP, Global Head, Value & Access, Oncology, Novartis
  • Nancy Ruscio-Bell, VP, Head of US Access Marketing & Oncology Enterprise Accounts, EMD Serono
  • Reg Waldeck, VP, Market Access Strategy Leader, Bayer

 

For program highlights visit the Reuters Event website.